3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Precancerous Conditions
3
Rectal Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenomatous Polyps
1
Interventions
Fluorouracil
29
Leucovorin
26
Oxaliplatin
25
Capecitabine
16
Irinotecan
14
Cetuximab
10
Bevacizumab
9
Radiotherapy
8
Panitumumab
5
Folfox protocol
5
Surgical Procedures, Operative
3
Levamisole
3
Celecoxib
3
tremelimumab
2
neratinib
2
napabucasin
2
durvalumab
2
cediranib
2
aflibercept
2
X-Rays
2
Tegafur
2
Radiofrequency Ablation
2
Psychiatric Rehabilitation
2
Preoperative Exercise
2
Octreotide
2
Mitomycin
2
Interviews as Topic
2
Immunoglobulin G
2
Folic Acid
2
Floxuridine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Colorectal Neoplasms
×
Selenium
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts